ETFs Hubei Jumpcan Pharmaceutical Co., Ltd.

600566

CNE0000018X6

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 16/01/2026			5-day change	1st Jan Change
26.28 ^CNY	-0.90%		+0.61%	-0.08%

04/01	Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 24, 2025.	CI
24/11	Hubei Jumpcan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	CI

ETFs positioned on Hubei Jumpcan Pharmaceutical Co., Ltd.

Name		Varia. Jan 1.	Weight	AuM
KRANESHARES MSCI ALL CHINA HEALTH CARE INDEX UCITS ETF - USD		-19.71%	0.42%	0 M€
NOMURA NEXT FUNDS EMERGING MARKET EQUITY MSCI-EM (UNHEDGED) ETF - JPY		+7.20%	0%	21 M€

HUBEI JUMPCAN PHARMACEUTICAL CO., LTD., formerly Hubei Hongcheng General Machinery Co., Ltd., is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The Company mainly distributes its products within domestic markets.

Employees

5,026

Sector

Pharmaceuticals

Calendar

18/04 - Q4 2025 Earnings Release

More about the company